Every 424B that Barnwell Industries, Inc. (BRN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BRN filings page.
Barnwell Industries, Inc. amends its January 30, 2026 prospectus supplement to update its at‑the‑market offering capacity: it may offer up to $4,297,700 of common stock through Roth Capital Partners under a previously filed Sales Agreement. The increase reflects a rise in the company’s public float and adjusts the 12‑month limit prescribed by General Instruction I.B.6 of Form S‑3.
The supplement notes a prior shelf capacity of $50,000,000, a prior Form S‑3 limit of $3,200,000, and that approximately $2,103,558 was sold under the I.B.6 allowance in the last 12 months. Shares outstanding were 14,233,259, with a public float of $12,893,200 based on 9,994,729 shares held by non‑affiliates at a reference price of $1.29 per share.
Barnwell Industries, Inc. is offering shares of its common stock in an at-the-market program under a Sales Agreement with Roth Capital Partners, permitting aggregate gross sales of up to $3,200,000 pursuant to this prospectus supplement, subject to the Form S-3 General Instruction I.B.6 offering limit.
The Sales Agreement permits sales from time to time through the Sales Agent as agent or principal; the Sales Agent will receive commissions of up to 2.5% of gross sales. The prospectus cites an example that, assuming sale of 3,168,317 shares at the February 20, 2026 closing price of $1.01, Barnwell would have up to 15,734,631 shares outstanding after the offering. Public float and the Form S-3 limitation govern how much may be sold without a further prospectus supplement.
Barnwell Industries, Inc. is registering 3,250,245 shares of common stock for resale by existing holders. This total includes 2,221,141 outstanding shares and 1,029,104 shares issuable upon exercise of common warrants issued in a November 2025 private placement.
The company will not sell any shares itself and will not receive proceeds from stockholder resales, but will receive cash only if warrants are exercised. As of January 5, 2026, 12,538,064 shares of common stock were issued and outstanding, providing context for potential dilution if the warrants are exercised.